Innovation matters, but it’s only part of the equation. The future of cancer care relies just as much on bridging the gaps between patients and health systems as it does on scientific breakthroughs.

Heath Naquin did a double take. Did the complicated tax changes he was reading through really mean what he thought they meant for the early stage medtech companies the Science Center advises? He started digging deeper and realized that these were issues startups needed to know about.

Your medtech, diagnostics or therapeutic technology might be built on the foundation of groundbreaking innovation with the potential to solve a critical problem in healthcare—but it never reaches its intended user. Why is this so often the case?

Oropharyngeal cancer – if you haven’t heard of it yet, chances are you will. It develops in the saliva-producing section of your throat (oropharynx), and oral and throat cancer is swiftly on the rise: with incidences increasing by 200% over the past 20 years, with another 30% increase projected by